bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 4, 2023
The
human
papillomavirus
(HPV)
oncoprotein
E7
is
a
relatively
short-lived
protein
required
for
HPV-driven
cancer
development
and
maintenance.
degraded
through
ubiquitination
mediated
by
cullin
1
(CUL1)
the
ubiquitin-conjugating
enzyme
E2
L3
(UBE2L3).
However,
proteins
are
maintained
at
high
levels
in
most
HPV-positive
cells.
A
previous
proteomics
study
has
shown
that
UBE2L3
CUL1
increased
knockdown
of
E3
ubiquitin
ligase
membrane-associated
ring-CH-type
finger
8
(MARCHF8).
We
have
recently
demonstrated
HPV
upregulates
MARCHF8
expression
keratinocytes
head
neck
(HPV+
HNC)
Here,
we
report
stabilizes
degrading
components
SKP1-CUL1-F-box
(SCF)
complex
HPV+
HNC
found
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(2)
Published: Feb. 1, 2024
Abstract
Membrane‐associated
RING‐CH
(MARCH)
family
proteins
were
recently
reported
to
inhibit
viral
replication
through
multiple
modes.
Previous
work
showed
that
human
MARCH8
blocked
Ebola
virus
(EBOV)
glycoprotein
(GP)
maturation.
Our
study
here
demonstrates
MARCH1
and
MARCH2
share
a
similar
pattern
in
restricting
EBOV
GP‐pseudotyped
infection.
Human
retain
GP
at
the
trans
‐Golgi
network,
reduce
its
cell
surface
display,
impair
virions
infectivity.
Furthermore,
we
uncover
host
proprotein
convertase
furin
could
interact
with
MARCH1/2
intracellularly.
Importantly,
P
domain
is
verified
be
recognized
by
MARCH1/2/8,
which
critical
for
their
blocking
activities.
Besides,
bovine
murine
also
proteolytic
processing.
Altogether,
our
findings
confirm
of
different
mammalian
origins
relatively
conserved
feature
cleavage,
provide
clues
subsequent
MARCHs
antiviral
studies
may
facilitate
development
novel
strategies
antagonize
enveloped
Viral
envelope
glycoproteins
are
crucial
for
viral
infections.
In
the
process
of
enveloped
viruses
budding
and
release
from
producer
cells,
presented
on
membrane
surface
as
spikes,
promoting
virus's
next-round
infection
target
cells.
However,
host
cells
evolve
counteracting
mechanisms
in
long-term
virus-host
co-evolutionary
processes.
For
instance,
cell
antiviral
factors
could
potently
suppress
replication
by
targeting
their
through
multiple
channels,
including
intracellular
synthesis,
glycosylation
modification,
assembly
into
virions,
binding
to
receptors.
Recently,
a
group
studies
discovered
that
some
proteins
specifically
recognized
proprotein
convertase
(PC)
furin
blocked
its
cleavage
glycoproteins,
thus
impairing
infectivity.
Here,
this
review,
we
briefly
summarize
several
such
analyze
roles
reducing
aiming
at
providing
insights
future
studies.
Journal of Virology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 16, 2024
ABSTRACT
The
human
papillomavirus
(HPV)
oncoprotein
E7
is
a
relatively
short-lived
protein
required
for
HPV-driven
cancer
development
and
maintenance.
degraded
through
ubiquitination
mediated
by
cullin
1
(CUL1)
the
ubiquitin-conjugating
enzyme
E2
L3
(UBE2L3).
However,
proteins
are
maintained
at
high
levels
in
most
HPV-positive
cells.
A
previous
proteomics
study
has
shown
that
UBE2L3
CUL1
increased
knockdown
of
E3
ubiquitin
ligase
membrane-associated
ring-CH-type
finger
8
(MARCHF8).
We
have
recently
demonstrated
HPV16
upregulates
MARCHF8
expression
keratinocytes
head
neck
(HPV+
HNC)
Here,
we
report
stabilizes
degrading
components
S-phase
kinase-associated
1-CUL1-F-box
complex
HPV+
HNC
found
cells
drastically
decreases
level
while
increasing
levels.
further
revealed
binds
to
ubiquitinates
enhances
protein.
Conversely,
overexpression
suppresses
tumor
growth
vivo
.
Our
findings
suggest
HPV-induced
prevents
degradation
ubiquitinating
proteins.
IMPORTANCE
Since
essential
virus
replication;
HPV
maintain
HPV-infected
can
be
efficiently
ubiquitinated
proteasomes
host
cell.
Mechanistically,
(UBE2L3)
play
an
role
degradation.
show
membrane
(MARCHF8)
induced
E6
blocking
proteasomes.
knockout
restores
expression,
decreasing
inhibiting
proliferation
Additionally,
or
growth.
results
maintains
cell
inducing
MARCHF8,
which
may
critical
tumorigenesis.
Pathogens,
Journal Year:
2024,
Volume and Issue:
13(2), P. 127 - 127
Published: Jan. 29, 2024
Influenza
virus
has
been
one
of
the
most
prevalent
and
researched
viruses
globally.
Consequently,
there
is
ample
information
available
about
influenza
lifecycle
pathogenesis.
However,
plenty
yet
to
be
known
determinants
pathogenesis
disease
severity.
exploits
host
factors
promote
each
step
its
lifecycle.
In
turn,
deploys
antiviral
or
restriction
that
inhibit
restrict
at
those
steps.
Two
broad
categories
can
exist
in
virus-infected
cells:
(1)
encoded
by
interferon-stimulated
genes
(ISGs)
(2)
constitutively
expressed
are
not
stimulated
interferons
(non-ISGs).
There
hundreds
ISGs
known,
many,
e.g.,
Mx,
IFITMs,
TRIMs,
have
characterized
infection
different
stages
blocking
viral
entry
progeny
release,
sequestering
degrading
components
interfering
with
synthesis
assembly,
(3)
bolstering
innate
defenses.
Also,
many
non-ISGs,
cyclophilins,
ncRNAs,
HDACs,
identified
similar
mechanisms.
This
review
provides
an
overview
non-ISGs
how
escapes
imposed
them
aims
improve
our
understanding
mechanisms
virus.
PLoS Pathogens,
Journal Year:
2023,
Volume and Issue:
19(9), P. e1011619 - e1011619
Published: Sept. 14, 2023
The
host
cell
membrane-associated
RING-CH
8
protein
(MARCH8),
a
member
of
the
E3
ubiquitin
ligase
family,
regulates
intracellular
turnover
many
transmembrane
proteins
and
shows
potent
antiviral
activities.
Generally,
2
modes
are
performed
by
MARCH8.
On
one
hand,
MARCH8
catalyzes
viral
envelope
glycoproteins
(VEGs)
ubiquitination
thus
leads
to
their
degradation,
which
is
cytoplasmic
tail
(CT)-dependent
(CTD)
mode.
other
traps
VEGs
at
some
compartments
(such
as
trans-Golgi
network,
TGN)
but
without
inducing
tail-independent
(CTI)
mode,
hijacks
furin,
cellular
proprotein
convertase,
block
cleavage.
In
addition,
C-terminal
tyrosine-based
motif
(TBM)
222YxxL225
also
plays
key
role
in
its
CTI
effects.
contrast
potency,
occasionally
hijacked
viruses
bacteria
enhance
invasion,
indicating
duplex
pathogenic
infections.
This
review
summarizes
MARCH8's
roles
how
evade
restriction,
shedding
light
on
novel
therapeutic
avenues.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 23, 2025
Viral
infectious
diseases,
caused
by
numerous
viruses
including
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
influenza
A
virus
(IAV),
enterovirus
(EV),
human
immunodeficiency
(HIV),
hepatitis
B
(HBV),
and
papillomavirus
(HPV),
pose
a
continuous
threat
to
global
health.
As
obligate
parasites,
rely
on
host
cells
replicate,
have
developed
defense
mechanisms
counteract
viral
infection.
Host
restriction
factors
(HRFs)
are
critical
components
of
the
early
antiviral
response.
These
cellular
proteins
inhibit
replication
spread
impeding
essential
steps
in
life
cycle,
such
as
entry,
genome
transcription
replication,
protein
translation,
particle
assembly,
release.
This
review
summarizes
current
understanding
how
with
primary
focus
their
diverse
against
range
viruses,
SARS-CoV-2,
virus,
enteroviruses,
papillomavirus.
In
addition,
we
highlight
crucial
role
these
shaping
host-virus
interactions
discuss
potential
targets
for
drug
development.
Cell Death and Disease,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: May 16, 2025
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
prevalent
malignant
tumors
digestive
system,
and
its
prevalence
currently
increasing.
The
current
study
aims
to
elucidate
mechanism
by
which
membrane-associated
RING-CH8
(MARCH8)
impedes
progression
HCC.
MARCH8
was
identified
as
a
distinct
prognostic
marker
for
recurrence-free
survival
(RFS)
overall
(OS)
in
patients
with
This
shows
that
hinders
lipid
deposition
suppressing
expression
key
enzymes
de
novo
synthesis
fatty
acids
(FAs)
via
RNA
sequencing,
untargeted
metabolomics,
series
vivo
vitro
experiments.
Further
experimental
validation
demonstrated
novel
E3
ligase
sterol
regulatory
element
binding
protein
1
(SREBP1).
And,
it
primarily
promoted
degradation
SREBP1,
thereby
involved
FAs.
In
conclusion,
this
has
"switch"
can
be
targeted
prevent
FA
HCC
cells.
finding
may
have
substantial
implications
discovering
innovative
therapeutic
strategies
Journal of Virology,
Journal Year:
2022,
Volume and Issue:
96(12)
Published: May 31, 2022
While
a
number
of
studies
have
demonstrated
that
human
Mx
proteins
can
inhibit
particular
herpesviruses
in
vitro
,
we
are
the
first
to
report
antiviral
activity
mouse
Mx1
(mMx1)
against
alphaherpesviruses
both
and
vivo
.
We
demonstrate
overexpressed
mMx1
endogenous
potently
restrict
HSV-1
growth
mMx1-mediated
inhibition
was
not
associated
with
virus
entry
and/or
import
viral
genome
into
nucleus,
but
rather
genomic
replication
as
well
subsequent
late
gene
expression.